港股異動 | 績後獲多家投行唱好 中集安瑞科(3899.HK)大幅拉昇超8%
格隆匯8月27日丨中集安瑞科(3899.HK)快速拉昇漲超8%,報11.14港元,暫成交5960萬港元,總市值225億港元。公司日前公佈,上半年實現收益79.4億元,同比增長49.3%;公司股東應占溢利3.83億元,同比增長77.5%。光大證券指出,公司三大業務板塊收入均大幅反彈,未來氫能消費增長潛力巨大,有望成為公司新的業績增長點,維持“買入”評級;華泰證券予“買入”評級,目標價上調至13.9港元,指公司天然氣及氫能等清潔能源產業發展進入快車道,公司能源運輸設備及儲存設備的需求快速增長;瑞信亦上調公司目標價至11.8港元,評級跑贏大市。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.